Clinical Trials Retatrutide is still moving through clinical development, meaning trials are ongoing
The infiltration degree, phenotype ratio, and substance secretion of immune cells promote cancer cells proliferation
As cysteine and glutathione are scavengers of free radicals (mainly reactive oxygen species (ROS)), they can abrogate the effects of the majority of oxidative or alkylating drugs used in cancer therapy, affording an important resistance mechanism
Hepatocyte growth factor controls the proliferation of cultured epidermal melanoblasts and melanocytes from newborn mice
Starting at a low dose helps minimize common side effects such as nausea, stomach discomfort, and fatigue
503A refers to a section of the Federal Food, Drug, and Cosmetic Act that governs compounding pharmacies operating under a licensed physician or APRN prescription